Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
ACCENDRA HEALTH INC/VA/ roe for the quarter ending 2026-06-30 was 54.84%, a 87.19% decline year-over-year.
ACCENDRA HEALTH INC/VA/ roe for the quarter ending 2026-03-31 was 232.83%, a change of 296.90% year-over-year.
ACCENDRA HEALTH INC/VA/ roe for the quarter ending 2025-12-31 was 238.76%, a change of 300.62% year-over-year.
ACCENDRA HEALTH INC/VA/ roe for the quarter ending 2025-09-30 was 312.09%, a change of 317.53% year-over-year.
ACCENDRA HEALTH INC/VA/ roe for fiscal 2025 was 238.76%, a change of 300.62% from fiscal 2024.
ACCENDRA HEALTH INC/VA/ roe for fiscal 2024 was -61.85%, a change of -57.48% from fiscal 2023.
ACCENDRA HEALTH INC/VA/ roe for fiscal 2023 was -4.37%, a 288.65% decline from fiscal 2022.
ACCENDRA HEALTH INC/VA/ roe for fiscal 2022 was 2.32%, a 90.19% decline from fiscal 2021.